150 related articles for article (PubMed ID: 36065807)
1. Clinical Diagnosis of Probable Cerebral Amyloid Angiopathy: Diagnostic Accuracy Meta-Analysis of the Boston Criteria.
Charidimou A; Boulouis G
Stroke; 2022 Dec; 53(12):3679-3687. PubMed ID: 36065807
[TBL] [Abstract][Full Text] [Related]
2. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
Charidimou A; Boulouis G; Frosch MP; Baron JC; Pasi M; Albucher JF; Banerjee G; Barbato C; Bonneville F; Brandner S; Calviere L; Caparros F; Casolla B; Cordonnier C; Delisle MB; Deramecourt V; Dichgans M; Gokcal E; Herms J; Hernandez-Guillamon M; Jäger HR; Jaunmuktane Z; Linn J; Martinez-Ramirez S; Martínez-Sáez E; Mawrin C; Montaner J; Moulin S; Olivot JM; Piazza F; Puy L; Raposo N; Rodrigues MA; Roeber S; Romero JR; Samarasekera N; Schneider JA; Schreiber S; Schreiber F; Schwall C; Smith C; Szalardy L; Varlet P; Viguier A; Wardlaw JM; Warren A; Wollenweber FA; Zedde M; van Buchem MA; Gurol ME; Viswanathan A; Al-Shahi Salman R; Smith EE; Werring DJ; Greenberg SM
Lancet Neurol; 2022 Aug; 21(8):714-725. PubMed ID: 35841910
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis.
Charidimou A; Farid K; Baron JC
Neurology; 2017 Oct; 89(14):1490-1498. PubMed ID: 28855406
[TBL] [Abstract][Full Text] [Related]
4. Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.
Switzer AR; Charidimou A; McCarter S; Vemuri P; Nguyen AT; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
Neurology; 2024 May; 102(10):e209386. PubMed ID: 38710005
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Boston Criteria v2.0/v1.5 for Cerebral Amyloid Angiopathy to Predict Recurrent Intracerebral Hemorrhage.
Fandler-Höfler S; Gattringer T; Enzinger C; Werring DJ
Stroke; 2023 Jul; 54(7):1901-1905. PubMed ID: 37264913
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample.
Zanon Zotin MC; Makkinejad N; Schneider JA; Arfanakis K; Charidimou A; Greenberg SM; van Veluw SJ
Neurology; 2024 Jan; 102(1):e207940. PubMed ID: 38165367
[TBL] [Abstract][Full Text] [Related]
7. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.
Charidimou A; Frosch MP; Al-Shahi Salman R; Baron JC; Cordonnier C; Hernandez-Guillamon M; Linn J; Raposo N; Rodrigues M; Romero JR; Schneider JA; Schreiber S; Smith EE; van Buchem MA; Viswanathan A; Wollenweber FA; Werring DJ; Greenberg SM;
Int J Stroke; 2019 Dec; 14(9):956-971. PubMed ID: 31514686
[TBL] [Abstract][Full Text] [Related]
8. Simplified Edinburgh and modified Boston criteria in relation to amyloid PET for lobar intracerebral hemorrhage.
Michiels L; Dobbels L; Demeestere J; Demaerel P; Van Laere K; Lemmens R
Neuroimage Clin; 2022; 35():103107. PubMed ID: 35853346
[TBL] [Abstract][Full Text] [Related]
9. Simplified Edinburgh CT Criteria for Identification of Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid Angiopathy.
Sembill JA; Knott M; Xu M; Roeder SS; Hagen M; Sprügel MI; Mrochen A; Borutta M; Hoelter P; Engelhorn T; Rothhammer V; Macha K; Kuramatsu JB
Neurology; 2022 May; 98(20):e1997-e2004. PubMed ID: 35314501
[TBL] [Abstract][Full Text] [Related]
10. Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation.
Auriel E; Charidimou A; Gurol ME; Ni J; Van Etten ES; Martinez-Ramirez S; Boulouis G; Piazza F; DiFrancesco JC; Frosch MP; Pontes-Neto OV; Shoamanesh A; Reijmer Y; Vashkevich A; Ayres AM; Schwab KM; Viswanathan A; Greenberg SM
JAMA Neurol; 2016 Feb; 73(2):197-202. PubMed ID: 26720093
[TBL] [Abstract][Full Text] [Related]
11. Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study.
Switzer A; Charidimou A; McCarter SJ; Vemuri P; Nguyen A; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
medRxiv; 2023 Nov; ():. PubMed ID: 37986913
[TBL] [Abstract][Full Text] [Related]
12. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population.
van Rooden S; van der Grond J; van den Boom R; Haan J; Linn J; Greenberg SM; van Buchem MA
Stroke; 2009 Sep; 40(9):3022-7. PubMed ID: 19556530
[TBL] [Abstract][Full Text] [Related]
13. Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy.
Wilson D; Hostettler IC; Ambler G; Banerjee G; Jäger HR; Werring DJ
J Neurol; 2017 Apr; 264(4):664-673. PubMed ID: 28154972
[TBL] [Abstract][Full Text] [Related]
14. Finger-Like Projections in Lobar Haemorrhage on Early Magnetic Resonance Imaging Is Associated with Probable Cerebral Amyloid Angiopathy.
Renard D; Parvu T; Thouvenot E
Cerebrovasc Dis; 2019; 47(3-4):121-126. PubMed ID: 31063997
[TBL] [Abstract][Full Text] [Related]
15. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
Knudsen KA; Rosand J; Karluk D; Greenberg SM
Neurology; 2001 Feb; 56(4):537-9. PubMed ID: 11222803
[TBL] [Abstract][Full Text] [Related]
16. Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: A systematic analysis of published and seven new cases.
Szalardy L; Fakan B; Maszlag-Torok R; Ferencz E; Reisz Z; Radics BL; Csizmadia S; Szpisjak L; Annus A; Zadori D; Kovacs GG; Klivenyi P
Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12946. PubMed ID: 38093468
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.
Martinez-Ramirez S; Romero JR; Shoamanesh A; McKee AC; Van Etten E; Pontes-Neto O; Macklin EA; Ayres A; Auriel E; Himali JJ; Beiser AS; DeCarli C; Stein TD; Alvarez VE; Frosch MP; Rosand J; Greenberg SM; Gurol ME; Seshadri S; Viswanathan A
Alzheimers Dement; 2015 Dec; 11(12):1480-1488. PubMed ID: 26079413
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.
Linn J; Halpin A; Demaerel P; Ruhland J; Giese AD; Dichgans M; van Buchem MA; Bruckmann H; Greenberg SM
Neurology; 2010 Apr; 74(17):1346-50. PubMed ID: 20421578
[TBL] [Abstract][Full Text] [Related]
19. Brain Glucose Metabolism in Cerebral Amyloid Angiopathy: An FDG-PET Study.
Bergeret S; Queneau M; Rodallec M; Landeau B; Chetelat G; Hong YT; Dumurgier J; Hugon J; Paquet C; Farid K; Baron JC
Stroke; 2021 Apr; 52(4):1478-1482. PubMed ID: 33611942
[TBL] [Abstract][Full Text] [Related]
20. Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage: diagnostic value of plain CT.
Baron JC; Boulouis G; Benzakoun J; Schwall C; Oppenheim C; Turc G; Varlet P
J Neurol; 2022 Apr; 269(4):2126-2132. PubMed ID: 34510255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
